183 related articles for article (PubMed ID: 38473953)
1. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
[No Abstract] [Full Text] [Related]
2. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
[No Abstract] [Full Text] [Related]
3. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
[TBL] [Abstract][Full Text] [Related]
6. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
8. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
[TBL] [Abstract][Full Text] [Related]
9. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry Imaging of In Vitro
Anschütz NH; Gerbig S; Ghezellou P; Silva LMR; Vélez JD; Hermosilla CR; Taubert A; Spengler B
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627264
[No Abstract] [Full Text] [Related]
11. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics reveals Cryptosporidium parvum infection disrupts cellular barriers.
Wang L; Cui Z; Li N; Liang G; Zhang X; Wang Y; Li D; Li X; Zhang S; Zhang L
J Proteomics; 2023 Sep; 287():104969. PubMed ID: 37463621
[TBL] [Abstract][Full Text] [Related]
13. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
[TBL] [Abstract][Full Text] [Related]
14. Identification of host protein ENO1 (alpha-enolase) interacting with Cryptosporidium parvum sporozoite surface protein, Cpgp40.
Wang Y; Li N; Liang G; Wang L; Zhang X; Cui Z; Li X; Zhang S; Zhang L
Parasit Vectors; 2024 Mar; 17(1):146. PubMed ID: 38504274
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
16. Cryptosporidium parvum maintains intracellular survival by activating the host cellular EGFR-PI3K/Akt signaling pathway.
Yang H; Zhang M; Wang X; Gong P; Zhang N; Zhang X; Li X; Li J
Mol Immunol; 2023 Feb; 154():69-79. PubMed ID: 36621060
[TBL] [Abstract][Full Text] [Related]
17. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response.
Li T; Liu H; Jiang N; Wang Y; Wang Y; Zhang J; Shen Y; Cao J
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009949. PubMed ID: 34818332
[TBL] [Abstract][Full Text] [Related]
19. In vitro growth inhibition of Theileria equi by bumped kinase inhibitors.
Gimenez F; Hines SA; Evanoff R; Ojo KK; Van Voorhis WC; Maly DJ; Vidadala RSR; Mealey RH
Vet Parasitol; 2018 Feb; 251():90-94. PubMed ID: 29426483
[TBL] [Abstract][Full Text] [Related]
20. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
